(Q84013368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1 reference

Robert C Owens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Andrew F Shorr

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

12 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

S23-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

30 January 2020

cites work

1 reference

Antimicrobial-resistant bacteria in the community setting

31 March 2020

1 reference

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

31 March 2020

1 reference

Hidden epidemic of macrolide-resistant pneumococci

31 March 2020

1 reference

Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics

31 March 2020

1 reference

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae

31 March 2020

1 reference

The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.

31 March 2020

1 reference

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

31 March 2020

1 reference

A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

31 March 2020

1 reference

Estimating health care-associated infections and deaths in U.S. hospitals, 2002

31 March 2020

1 reference

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study

31 March 2020

1 reference

The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance

31 March 2020

1 reference

Trends in antimicrobial drug development: implications for the future

31 March 2020

1 reference

Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections

31 March 2020

1 reference

Optimizing antimicrobial dosing in the critically ill patient

31 March 2020

1 reference

Clinical pharmacodynamics of quinolones

31 March 2020

1 reference

Use of pharmacokinetics and pharmacodynamics in a failure analysis of community-acquired pneumonia: implications for future clinical trial study design

31 March 2020

1 reference

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

31 March 2020

1 reference

Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.

31 March 2020

1 reference

The antimicrobial armamentarium: evaluating current and future treatment options

31 March 2020

1 reference

Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection

31 March 2020

1 reference

Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.

31 March 2020

1 reference

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

31 March 2020

1 reference

Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics

31 March 2020

1 reference

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials

31 March 2020

1 reference

Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults

31 March 2020

1 reference

Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults

31 March 2020

1 reference

Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team

31 March 2020

1 reference

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

31 March 2020

1 reference

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

31 March 2020

1 reference

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm

31 March 2020

1 reference

Back to the future: using aminoglycosides again and how to dose them optimally

31 March 2020

1 reference

Pharmacokinetic dosing of aminoglycosides: a controlled trial

31 March 2020

1 reference

Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.

31 March 2020

1 reference

Can PK/PD be used in everyday clinical practice

31 March 2020

1 reference

Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia

31 March 2020

1 reference

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem

31 March 2020

1 reference

Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusion

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.2146/090087D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19502225%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference